The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
The latest report by IMARC, titled “ HydrocephalusShuntsMarket:GlobalIndustryTrends,Share,Size,Growth,OpportunityandForecast 2023-2028
” " the global hydrocephalus shunts market reached a value of US$ 433.6 Million in 2022.
Hydrocephalus is the occurrence of a medical condition when the cerebrospinal fluid (CSF) accumulated in the brain results in increased intracranial pressure in the skull. It is generally caused by a variety of different diseases and injuries, including an obstruction to the CSF flow.
It is commonly treated by hydrocephalus shunts that are generally adopted by healthcare professionals in the treatment of hydrocephalus. It is a flexible tube that is placed in the area where cerebrospinal fluid (CSF) is produced, which allows the draining of CSF to a different part of the body where it can be absorbed.
Request Free Sample Report: https://www.imarcgroup.com/hydrocephalus-shunts-market/requestsample
The global market is primarily driven by the increasing prevalence of neurological disorders among individuals. This can be attributed to the growing geriatric population and the hectic lifestyles led by working professionals. With a considerable rise in the number of hydrocephalic patients, there has been a continuous increase in the demand for hydrocephalus shunts across the globe. Due to continual technological advancements, neurosurgeons are inclining towards advanced programmable valves, shunts and antisiphon devices to avoid the siphoning effect over cerebrospinal fluid, which is further creating a positive market outlook. The market is further driven by numerous initiatives undertaken by private and government organizations to spread awareness regarding hydrocephalus.
Other factors, including continuous developments in the healthcare infrastructure, widespread improvements in medical facilities across rural and geographical extended areas, the rising number of accidents, and extensive research and development (R&D) activities conducted by key players, are also influencing the market. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 561.8 Million by 2028, growing at a CAGR of 3.99% during 2023-2028.
Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).
MarketSummary:
BreakupbyType:
• Ventriculo-Peritoneal
• Ventriculo-Atrial
• Ventriculo-Pleural
• Lumbo-Peritoneal
BreakupbyProductType:
• Hydrocephalus Valves
• Adjustable Pressure Valves
• Fix Pressure Valves
• Hydrocephalus Catheters
BreakupbyAgeGroup:
• Infants
• Children
• Adults
BreakupbyEndUser:
• Hospitals
• Ambulatory Surgical Centers
BreakupbyRegion:
• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
CompetitiveLandscapewithKeyPlayers:
• Argi Group
• B. Braun Melsungen AG
• Christoph Miethke GmbH & Co. KG
• G. Surgiwear Ltd.
• HLL Lifecare Limited
• Integra LifeSciences
• Kaneka Medix Corporation (Kaneka Corporation)
• Medtronic Plc
• Natus Medical Incorporated
• Sophysa
• Spiegelberg GmbH & Co. KG (SHS Medizintechnik Holding GmbH)
• TKB Corporation
ViewFullReportwithTOC&ListofFigure:
https://www.imarcgroup.com/hydrocephalus-shunts-market
We are the trusted business partners to the world's leading corporates, governments, and institutions
We are the trusted business partners to the world's leading corporates, governments, and institutions
© 2019 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
